One-glance verdict
$16.75 our estimate vs market $7.08
Wall Street consensus: $20.00 (19.4% higher than our fair-value estimate)
58% below our estimate, below the bear case
Fundamentals snapshot
RMTI · NCM · Healthcare · Drug Manufacturers - Specialty & Generic
Current price
$7.08
52-week range
$4.89 - $12.90
Market cap
$28.54M
One-glance verdict
Wall Street consensus: $20.00 (19.4% higher than our fair-value estimate)
58% below our estimate, below the bear case
Balance sheet
Net cash $10.86M. Interest coverage shows how many times profit covers the interest bill.
What stands out
What this company does
Rockwell Medical makes and sells products that help people with kidney failure through dialysis, which is a process to remove waste from their blood when their kidneys can't. Their main products are different kinds of concentrates that go into the dialysis machines, and the money they make primarily comes from selling these essential supplies to dialysis clinics. This matters because it shows how the company earns its living by providing critical items for a vital medical treatment.
"How the company got here" "Rockwell Medical, Inc. was founded in 1996 and is headquartered in Wixom, Michigan. The company has evolved over the years, with a name change from Rockwell Medical Technologies, Inc. to Rockwell Medical, Inc. in June 2012. Rockwell Medical is a healthcare company focused on developing, manufacturing, and distributing hemodialysis products for dialysis providers worldwide. The company's mission is to provide high-quality products and excellent customer service to dialysis clinics and the patients they serve. Rockwell Medical aims to deliver exceptional value to the healthcare system and positively impact the lives of hemodialysis patients through innovative, long-term growth strategies. The company has been recognized for its workplace culture, being certified as a Great Place to Work® for multiple consecutive years and named a Fortune Best Workplaces in Manufacturing & Production." "What it actually does" "Rockwell Medical, Inc. develops, manufactures, and distributes a range of hemodialysis products essential for patients with end-stage kidney disease. These products are crucial for dialysis providers, helping to sustain patients' lives by removing toxins and balancing electrolytes in their bloodstream. The company's offerings include various types of dialysis concentrates, such as citric acid, dry acid, and bicarbonate concentrates, as well as ancillary products like cleaning solutions and water softener salt pellets. Rockwell Medical is a significant supplier in the U.S. market for these essential dialysis supplies." "Concentrate Products" "This segment represents Rockwell Medical's core business, focusing on the production and sale of hemodialysis concentrates. These concentrates, including liquid and dry acid and bicarbonate solutions, are mixed with purified water to create the dialysate used in hemodialysis treatments. Dialysis concentrates are vital for removing waste products and excess fluid from the blood of patients whose kidneys are not functioning properly. This business line is the largest contributor to Rockwell Medical's revenue, making up the vast majority of its sales." "Ancillary Products and Other Supplies" "Beyond its primary concentrate offerings, Rockwell Medical also provides a variety of ancillary products and supplies that support the hemodialysis process. These items include cleaning solutions for equipment, descalers to maintain machinery, testing supplies to ensure proper function, and water softener salt pellets used in water purification systems for dialysis. While not as significant in revenue as the concentrate products, these ancillary items are important for the complete operation of dialysis centers and contribute to the company's overall product portfolio." "What management is betting on now" "Rockwell Medical is pursuing a long-term growth strategy focused on expanding its global presence and diversifying its product offerings beyond its core U.S. hemodialysis concentrates business. The company recently announced a significant acquisition of Vantive's hemodialysis assets, which includes concentrates, machines, and water treatment systems, aiming to transform Rockwell into a more diversified global supplier. This strategic move is expected to significantly increase the company's annual revenue and broaden its commercial reach. Management is also focused on operational improvements, such as enhancing manufacturing efficiency and investing in quality and regulatory compliance, to support this expansion and drive profitability."
Price history
Earnings history
Click any quarter to read the call summary and what the numbers say.
Is it cheap or expensive?
Wall Street consensus is the average analyst price target: $20.00 (19.4% higher than our fair-value estimate).
Our most-likely fair value is $16.75 a share — about 136.6% above today's price of $7.08, so the stock currently looks cheap (undervalued).
Is it drowning in debt?
Net cash $10.9M - more cash than debt. Interest coverage -4.2x.
Rockwell Medical, Inc.'s profit covers its interest bill about 0.0 times over. which is weaker than most peers shown here and 3 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.
Total debt $13.93M Interest coverage -4.17x This is the baseline the peer rows are being compared against.
Total debt $872.00K Interest coverage 1,146.00x This peer still has a real interest-payment cushion, while RMTI does not.
Total debt $7.46M Interest coverage -98.59x Neither company has much profit cushion over interest right now.
Total debt $973.89K Interest coverage -162.33x Neither company has much profit cushion over interest right now.
Total debt $2.66M Interest coverage -310.21x Neither company has much profit cushion over interest right now.
What you should know
The numbers
Tap any ? icon to learn what it means.
Valuation
Profitability
Health
Growth
Cash flow
Dividend
Metric explainer
Debt comparison
What you should know